Smart Insulin Pens are Associated with Improved Clinical Outcomes at Lower Cost Versus Standard-of-Care Treatment of Type 1 Diabetes in Sweden: A Cost-Effectiveness Analysis
Authors 0
- Author list not loaded yet.
Cited by 5 stored of 68
5 results
5 results